It is not recommended to take other medications that contain paracetamol.
With the simultaneous administration of barbiturates, anticonvulsants, rifampicin, the risk of hepatotoxic action is significantly increased.
Long-term use of barbiturates reduces the effectiveness of paracetamol.
The concomitant use of paracetamol in high doses increases the effect of anticoagulant drugs.
Prolonged sharing of paracetamol and other non-steroidal anti-inflammatory drugs increases the risk of developing analgesic nephropathy and renal papillary necrosis, the onset of the terminal stage of renal failure.
Simultaneous long-term use of paracetamol in high doses and salicylates increases the risk of developing kidney or bladder cancer.
Dextromethorphan increases the effect of narcotic antitussive drugs and other drugs that depress the central nervous system.It is potentially possible to interact with monoamine oxidase inhibitors (taking dextromethorphan at the time of taking monoamine oxidase inhibitors should be avoided).
Monoamine oxidase inhibitors (including furazolidone, procarbazine, selegiline) with simultaneous application can cause adrenergic crisis, collapse, coma, dizziness, agitation, increased blood pressure, hyperpyrexia, intracranial bleeding, lethargy, nausea, spasms, tremor.